State Of Alaska, Department Of Revenue Xencor Inc Transaction History

State Of Alaska, Department Of Revenue

$9.79 Billion
Q3 2025

A detailed history of State Of Alaska, Department Of Revenue transactions in Xencor Inc stock. As of the latest transaction made, State Of Alaska, Department Of Revenue holds 35,888 shares of XNCR stock, worth $540,832. This represents 0.0% of its overall portfolio holdings.

Number of Shares

35,888

Previous 42,351 15.26%

Holding current value

$540,832

Previous $332,000 26.51%

% of portfolio

0.0%

Previous 0.0%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Oct 23, 2025	SELL	$7.0 - $11.73 $45,241 - $75,810	-6,463 Reduced 15.26%	35,888 $420,000
Q2 2025 Jul 16, 2025	BUY	$7.52 - $11.26 $26,876 - $40,243	3,574 Added 9.22%	42,351 $332,000
Q1 2025 Apr 21, 2025	SELL	$10.64 - $24.13 $10,597 - $24,033	-996 Reduced 2.5%	38,777 $412,000
Q4 2024 Jan 27, 2025	BUY	$19.43 - $26.84 $87,182 - $120,431	4,487 Added 12.72%	39,773 $913,000
Q3 2024 Oct 24, 2024	SELL	$15.7 - $21.65 $14,412 - $19,874	-918 Reduced 2.54%	35,286 $709,000
Q2 2024 Aug 05, 2024	SELL	$18.21 - $24.5 $16,043 - $21,584	-881 Reduced 2.38%	36,204 $685,000
Q1 2024 Apr 19, 2024	SELL	$18.65 - $26.52 $6,825 - $9,706	-366 Reduced 0.98%	37,085 $820,000
Q4 2023 Jan 19, 2024	SELL	$16.53 - $21.42 $4,760 - $6,168	-288 Reduced 0.76%	37,451 $795,000
Q3 2023 Oct 16, 2023	SELL	$20.08 - $25.39 $40,099 - $50,703	-1,997 Reduced 5.03%	37,739 $760,000
Q2 2023 Jul 24, 2023	SELL	$24.77 - $29.9 $32,176 - $38,840	-1,299 Reduced 3.17%	39,736 $992,000
Q1 2023 Apr 17, 2023	SELL	$25.95 - $36.95 $17,931 - $25,532	-691 Reduced 1.66%	41,035 $1.14 Million
Q4 2022 Jan 11, 2023	BUY	$24.79 - $30.86 $9,792 - $12,189	395 Added 0.96%	41,726 $1.09 Million
Q3 2022 Oct 20, 2022	SELL	$24.62 - $32.44 $91,241 - $120,222	-3,706 Reduced 8.23%	41,331 $1.07 Million
Q2 2022 Jul 08, 2022	BUY	$19.74 - $29.01 $85,967 - $126,338	4,355 Added 10.7%	45,037 $1.23 Million
Q1 2022 Apr 14, 2022	SELL	$26.68 - $41.63 $19,343 - $30,181	-725 Reduced 1.75%	40,682 $1.09 Million
Q4 2021 Jan 12, 2022	SELL	$33.67 - $43.44 $38,383 - $49,521	-1,140 Reduced 2.68%	41,407 $1.66 Million
Q3 2021 Oct 07, 2021	BUY	$30.65 - $35.68 $69,054 - $80,387	2,253 Added 5.59%	42,547 $1.39 Million
Q2 2021 Jul 12, 2021	BUY	$34.33 - $44.68 $36,733 - $47,807	1,070 Added 2.73%	40,294 $1.39 Million
Q1 2021 Apr 09, 2021	SELL	$40.81 - $53.88 $224,455 - $296,340	-5,500 Reduced 12.3%	39,224 $1.69 Million
Q4 2020 Jan 08, 2021	SELL	$36.63 - $47.63 $320,219 - $416,381	-8,742 Reduced 16.35%	44,724 $1.95 Million
Q3 2020 Oct 05, 2020	BUY	$30.09 - $43.02 $201,302 - $287,803	6,690 Added 14.3%	53,466 $2.07 Million
Q2 2020 Jul 06, 2020	BUY	$27.76 - $33.42 $27,760 - $33,420	1,000 Added 2.18%	46,776 $1.52 Million
Q1 2020 Apr 06, 2020	BUY	$20.69 - $37.79 $176,278 - $321,970	8,520 Added 22.87%	45,776 $1.37 Million
Q4 2019 Jan 07, 2020	SELL	$32.75 - $41.43 $19,027 - $24,070	-581 Reduced 1.54%	37,256 $1.28 Million
Q3 2019 Oct 02, 2019	BUY	$33.73 - $46.27 $1.28 Million - $1.75 Million	37,837 New	37,837 $1.28 Million

Others Institutions Holding XNCR

# of Institutions

209

Shares Held

82M

Call Options Held

Put Options Held

View Full List

About Xencor Inc

Ticker XNCR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,698,100
Market Cap $900M
Description
Xencor, Inc., a clinical stage biopharmaceutical company, focuses on the discovery and development of engineered monoclonal antibody and cytokine therapeutics to treat patients with cancer and autoimmune diseases. The company provides Sotrovimab that targets the SARS-CoV-2 virus; Ultomiris for the treatment of patients with paroxysmal nocturnal ...

More about XNCR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of State Of Alaska, Department Of Revenue, based on Form 13F filings with the SEC.

News

Stay updated on State Of Alaska, Department Of Revenue with notifications on news.

Account

State Of Alaska, Department Of Revenue Xencor Inc Transaction History